Anti-Covid vaccine: with Pfizer or Moderna, the risk of myocarditis remains in general "very rare" for the Drug Safety Agency

Anti-Covid vaccine: with Pfizer or Moderna, the risk of myocarditis remains in general “very rare” for the Drug Safety Agency

As part of the reinforced surveillance system for vaccines against Covid-19, the EPI-PHARE group has carried out a new pharmacoepidemiology study on the risk of myocarditis after injection of an mRNA vaccine from Pfizer (Comirnaty) and Modern (Spikevax). According to new data released by the ANSM on July 22, 2022, the risk of myocarditis increases …

Anti-Covid vaccine: with Pfizer or Moderna, the risk of myocarditis remains in general “very rare” for the Drug Safety Agency Read More »